MB
Marc Boudvillain
7
Documents
Identifiants chercheurs
- marc-boudvillain
- 0000-0002-6398-9122
- IdRef : 096361409
Présentation
- **CNRS Research director** and group Leader at CBM
- **Deputy director** of CBM since January 2018.
Education
---------
- **PhD Thesis** in Biochemistry and Molecular Biophysics, University of Orléans (1996).
- **Master of Science** (specialty: Biological Chemistry) from the Universities of Orléans, Paris Descartes, and Paris Sud (joint program, 1992).
Professional experience
-----------------------
- **Tenured Scientist** at CNRS, CBM since October 1999. Biochemistry of RNA and RNA-protein complexes; Regulation of bacterial transcription; RNA helicase mechanisms
- **Postdoctoral Research Scientist** at Columbia University and Howard Hugues Medical Institute (New York, USA). Biochemistry of RNA; Structure, function and catalysis by group II intron ribozymes (1996-1999).
- **Graduate Research Scientist** at CBM. Nucleic acid Biochemistry; Inorganic chemistry; Engineering of synthetic Pt(II)-based metalloribozymes (1993-1996).
Publications
- 1
- 1
- 1
- 1
- 1
- 7
- 5
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why?Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, 2, Plenum Press, New'Tork, USA, pp.17-25, 1996
Chapitre d'ouvrage
hal-02097755v1
|
Procédé de pontage sélectif et irréversible d'oligonucléotides platinés sur de l'ARN et ses applicationsFrance, Patent n° : WO1998018915A2. 1996
Brevet
hal-02097839v1
|